Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus - Wikidata - awgldk - TriplyDB

Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus

Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus

http://www.wikidata.org/entity/Q36095086

about

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model Evolving Rapid Methicillin-resistant Staphylococcus aureus Detection: Cover All the Bases.Epidemiology and outcomes of community-onset methicillin-susceptible Staphylococcus aureus bacteraemia in a university hospital in Singapore.Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois.New perspectives of infections in cardiovascular disease Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Clinical management of Staphylococcus aureus bacteremia: a review.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Predictors of mortality in Staphylococcus aureus Bacteremia Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections.Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia.Prevention and management of central line-associated bloodstream infections in hospital practice.Metastatic complications of bloodstream infections in hemodialysis patients.The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.Bad bacteria in acute appendicitis: rare but relevant.Adverse Events Lead to Drug Discontinuation More Commonly among Patients Who Receive Nafcillin than among Those Who Receive Oxacillin.Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort.Ventilator-associated pneumonia by methicillin-susceptible Staphylococcus aureus: do minimum inhibitory concentrations to vancomycin and daptomycin matter?Empirical combination of a β-lactam to vancomycin may not improve outcomes of methicillin-susceptible Staphylococcus aureus bacteremia, compared to vancomycin monotherapy.Evaluation of MRSASelect (™) chromogenic medium for the early detection of methicillin-resistant Staphylococcus aureus from blood cultures.Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model.Coagulase-negative Staphylococcus bacteraemia accounts for one third of Staphylococcus bacteraemia in a French university hospital.Redeploying β-Lactams Against Staphylococcus aureus: Repurposing With a Purpose.Effectiveness of Vancomycin or Beta-Lactam Therapy in Ampicillin-Susceptible Enterococcus spp. Bloodstream Infections.Impact of rapid diagnosis of Staphylococcus aureus bacteremia from positive blood cultures on patient management.Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience.Combination of Vancomycin and β-Lactam Therapy for Methicillin-ResistantStaphylococcus aureusBacteremia: A Pilot Multicenter Randomized Controlled Trial Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations

P2860

Q21261829-15AA2847-1F1A-49E8-A89F-F7BFD7C885ED Q28481497-F0E518C5-A26C-497E-BDB2-50F55FBF8268 Q30235503-BEDAFA5C-4FCC-44E3-83A9-8D4DFE070792 Q33318589-A81C2BBD-7106-4D0D-A837-B6957D1C8065 Q33483064-1B87958A-B8AF-4CF2-B0F8-7CC669825C00 Q33587960-2C75BB4E-3BE3-4E14-852E-8E37E2176FC0 Q33700986-C8DA7714-ED8A-485D-BB8D-B43EBBBDC3E2 Q34157657-9D14B1B3-5F9E-4A69-B9FC-D4CC5DCF0E79 Q34441035-E2801C1A-BA81-425F-982B-55324C715D98 Q34478074-6DD31ED8-3DB4-4C1A-BC7B-7FA48EB895DF Q35940556-7ECE395F-3A72-49A3-8D00-4154FB77E351 Q35960730-B799802E-6ED8-43C3-91C4-197356ACF009 Q36026942-DB89446E-7EAE-46E3-8AB6-81E88CD8FF75 Q36576652-3F576FE7-EA7D-40D8-ADEB-114641E31DF7 Q36748977-016C050E-B3EA-4582-90AE-5E25F47D0AED Q36836505-933C3B3F-95D9-4EC3-A8CA-5521AE87E260 Q37800310-FB911A3F-47B3-4918-8346-83A17B6BEC9B Q37821604-6E951689-37D0-422E-AE13-5C05220C4D56 Q37955286-B79851A2-E8DB-49E0-BA7D-0A8C7BFF87FB Q37992486-F3F616F0-652D-444E-BA49-503933B314F8 Q38070697-5D0E2EE4-831B-4BF9-B727-303DF26102D1 Q38132301-D87765D7-578F-4D3D-BC1C-281B24B0135A Q38677990-716184FF-59E0-4792-A761-55307E8DD657 Q38895155-799B266C-DD7A-46ED-BA3F-AE4C319FBF23 Q40093594-FFC9EE87-72DB-4D2B-913A-2D4141F75C91 Q40264307-A6ED634F-6784-4021-8D14-084238E38FCD Q40375415-2BA9409C-2FB9-41C9-A3E6-A162ADAA882E Q41896768-7FF02789-5398-4BA5-A90F-B0148F77D1BB Q42929761-9261B4D5-195A-4012-8D49-17A0BF09D723 Q42943128-52833722-5C57-4143-BA09-708B1966E632 Q43021553-DCF2D24D-CD9B-40FE-B820-8FA88A958679 Q45331165-4024693D-3B40-4043-BF65-C3C3975236E9 Q45961041-FDCF4EC4-D5D4-41CC-BD8E-3DBAE1804CF2 Q48547085-7D6C2671-F344-4EB2-929B-EFB2C51C4C06 Q50498047-3ED54B63-4895-4143-902A-CD5B763B4566 Q54785836-32E1677F-7D86-40E6-B619-E7B5A7116D76 Q57763098-A90442C0-CF36-4FBF-B046-1A69E12E3F14 Q57763234-C77D2E55-DC34-41DA-8178-1D4D55882822

P2860

Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus

http://www.wikidata.org/entity/Q36095086

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Impact of empirical-therapy se ...... ceptible Staphylococcus aureus

@ast

Impact of empirical-therapy se ...... ceptible Staphylococcus aureus

@en

type

label

Impact of empirical-therapy se ...... ceptible Staphylococcus aureus

@ast

Impact of empirical-therapy se ...... ceptible Staphylococcus aureus

@en

prefLabel

Impact of empirical-therapy se ...... ceptible Staphylococcus aureus

@ast

Impact of empirical-therapy se ...... ceptible Staphylococcus aureus

@en

P1433

Q36095086-EEAC98E9-4DA7-4360-B545-8E60987209CA

P1476

Q36095086-096A53AE-E844-4F60-A6C7-47303B89C3C6

P2093

Q36095086-17BF3E71-21A8-4B4D-918B-A86F4AD80467

Q36095086-2C304EB3-FB85-472E-AFBE-BBCD6F23CEF6

Q36095086-95851D0D-5702-4EB1-A52B-4FDE50455200

Q36095086-CD94CFFA-3CAD-44B3-8EBB-F89123DA8FB5

P2860

Q36095086-04BA94F2-CABC-40B9-82EC-12136CC56E21

Q36095086-1AA5B51D-35B4-4F12-AD6C-EB82CC3149D6

Q36095086-2913AC7C-F487-43BC-A2DF-5BACCE6B69CF

Q36095086-4272770C-3B74-4704-9FDB-DB167918F8C9

Q36095086-45EB7D81-4697-4579-8323-9404823CA861

Q36095086-48DF361B-BD21-47AA-A94B-C02C71A9E021

Q36095086-4F369D34-5ACC-4775-A80F-47FFCF8182F3

Q36095086-600A7EEC-D597-4003-832B-9187B5428C6D

Q36095086-633D4128-E9C7-4225-BAAA-0E75C8826EB9

Q36095086-70B31D1B-54AB-47BF-8A5E-DCD62796298E

P304

Q36095086-2A5C46B6-F517-4232-927B-AC1707129A0A

P31

Q36095086-DEC383D5-D082-42B5-93C8-B7C59F791837

P356

Q36095086-72AD6097-A940-4232-9D18-B148B4A8EECC

P407

Q36095086-4098AAA4-FD76-4115-995C-417DDCAD49D4

P433

Q36095086-D54CB9F3-1D51-43B1-ABCF-1B7D0BC3AD79

P478

Q36095086-6CB99596-D831-42F1-9A93-7E3907D64EE0

P577

Q36095086-7D8C1746-E761-438C-A6FA-BEEAC43D226D

P698

Q36095086-D8AC3CA3-AC37-431F-B431-FDC4580CFFD4

P932

Q36095086-2FD8F665-0040-425C-9F25-9406ECBD75CB

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Impact of empirical-therapy se ...... ceptible Staphylococcus aureus

@en

P2093

Donald P Levine

http://www.w3.org/2001/XMLSchema#string

Michael J Rybak

http://www.w3.org/2001/XMLSchema#string

Peggy S McKinnon

http://www.w3.org/2001/XMLSchema#string

Thomas P Lodise

http://www.w3.org/2001/XMLSchema#string

P2860

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis

Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms

Outcome assessment of minimizing vancomycin monitoring and dosing adjustments.

Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Impact of Gram-positive resistance on outcome of nosocomial pneumonia.

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.

Infective endocarditis in the narcotic addict.

Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

P304

3731-3733

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00101-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17664322

http://www.w3.org/2001/XMLSchema#string

P932

2043293

http://www.w3.org/2001/XMLSchema#string